论文部分内容阅读
目的探讨宫颈癌术后补充放疗的临床价值。方法回访60例宫颈癌术后补充放疗的患者,并对其治疗结果进行临床对比分析。结果60例宫颈癌术后补充放疗的患者中,5年生存率56.7%。其中47例在术后1个月以内行补充放疗,5年生存率66%(31/47);13例是在手术1个月后接受的放疗,5年生存率23%(3/13)。结论宫颈癌患者的治疗应规范化,并且术后补充放疗应尽早进行,以争取较好的疗效。
Objective To investigate the clinical value of postoperative radiotherapy for cervical cancer. Methods A total of 60 patients with postoperative radiotherapy of cervical cancer were retrospectively reviewed. The clinical outcomes of the treatment were compared. Results 60 patients with cervical cancer postoperative radiotherapy patients, the 5-year survival rate of 56.7%. Among them, 47 patients received radiotherapy within one month after operation, and the 5-year survival rate was 66% (31/47). Thirteen patients underwent radiotherapy one month after surgery and the 5-year survival rate was 23% (3/13) . Conclusion The treatment of cervical cancer patients should be standardized, and postoperative radiotherapy should be carried out as soon as possible in order to strive for better efficacy.